D. E. Shaw & Co »

Revance Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Revance Therapeutics shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $29M 38M 0.76
2023-09-30 $31M 38M 0.80
2023-06-30 $36M 34M 1.06
2023-03-31 $42M 34M 1.23

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Revance Therapeutics

Franklin Resources
D. E. Shaw & Co
Graham Capital Management
Context Capital Management
Aviva
Highbridge Capital Management
SSI Investment Management
Calamos Advisors
Amundi
Credit Suisse
CSS
Citigroup
First Hawaiian Bank
William Blair $ Company
Barclays

View all funds holding Revance Therapeutics